Medically reviewed by Dr. Tom Biernacki, DPM
Board-certified podiatric surgeon | Balance Foot & Ankle, Howell & Bloomfield Hills, MI
Last reviewed: May 2026
The most important clinical decision with Foot and Ankle Arthritis Treatment 2026 | DPM isn’t which treatment to choose — it’s identifying which subtype you have first. Our podiatrists see patients treated for the wrong subtype for months before the correct diagnosis leads to full resolution. Call (810) 206-1402 — expert podiatric care across Michigan.

| Arthritis Type | Joints Affected | Onset | Key Findings | First-Line Treatment |
|---|---|---|---|---|
| Osteoarthritis (OA) | Ankle, 1st MTP (hallux rigidus), subtalar, midfoot | Gradual; age-related or post-traumatic | Joint space narrowing; osteophytes; stiffness in AM | Orthotics; stiff-soled shoes; injections; activity modification |
| Rheumatoid Arthritis (RA) | MTP joints (2nd–5th first); then subtalar, ankle | Bilateral symmetric; systemic signs | Warm joints; elevated RF/CCP; erosions; subluxation | DMARD therapy (rheumatology); accommodative orthotics |
| Post-traumatic Arthritis | Ankle, subtalar; any joint after fracture or dislocation | Develops 5–10 years after injury | History of ankle fracture or dislocation; progressive pain | Orthotics; bracing; injection; fusion or replacement at end-stage |
| Gout | 1st MTP (podagra); ankle; subtalar | Sudden acute flares; recurrent | Elevated uric acid; needle-shaped MSU crystals on aspiration | Colchicine/NSAIDs (acute); allopurinol/febuxostat (prevention) |
| Psoriatic Arthritis | DIP joints; enthesopathy (Achilles, plantar fascia) | Asymmetric; skin/nail psoriasis | Dactylitis (sausage digit); enthesopathy; elevated CRP | Rheumatology (biologics); enthesopathy management |
| Joint | Conservative Options | Injection Options | Surgical Option |
|---|---|---|---|
| Ankle (tibiotalar) | Rocker-sole shoe; Arizona AFO; physical therapy | Cortisone; hyaluronic acid; PRP | Total ankle replacement or ankle fusion |
| Subtalar | UCBL orthotic; lace-up ankle brace; activity modification | Fluoroscopy-guided cortisone or PRP | Subtalar fusion (isolated) |
| 1st MTP (Hallux Rigidus) | Stiff-soled shoe; Morton’s extension orthotic; rocker sole | Cortisone; PRP; viscosupplementation | Cheilectomy (mild–moderate); arthrodesis (severe) |
| Midfoot (Lisfranc / naviculocuneiform) | Custom rigid orthotic; rocker sole shoe | Ultrasound-guided cortisone | Midfoot fusion (Lisfranc or naviculocuneiform) |
| 2nd–5th MTP | Metatarsal pad; extra-depth shoes; custom orthotic | Cortisone (small joint) | Arthroplasty or fusion |
Medically reviewed by Dr. Tom Biernacki, DPM, FACFAS
Board-certified podiatric surgeon | Balance Foot & Ankle | Last reviewed: May 2026
Quick answer: Foot and ankle arthritis describes progressive cartilage loss in one or more of the 28 joints of the foot and ankle. The most common types are osteoarthritis, post-traumatic arthritis, and inflammatory arthritis (rheumatoid, psoriatic, gout). Treatment follows a hierarchy: mechanical offloading and activity modification first, then anti-inflammatory treatment, orthotics, and joint injections — with surgery (cheilectomy, osteotomy, or arthrodesis) reserved for cases failing conservative care. Most patients achieve meaningful relief without surgery when treatment is started early.
Watch Dr. Tom Biernacki DPM explain foot and ankle arthritis — can cartilage regrow? — MichiganFootDoctors YouTube
Understanding Foot & Ankle Arthritis: The Mechanism
The foot and ankle contain 28 bones, 30+ joints, and over 100 ligaments — far more articular complexity than most patients realize. Arthritis in this region is not a single diagnosis but a final common pathway shared by multiple distinct pathologic processes, each with different causes, imaging characteristics, and treatment implications.
In osteoarthritis (OA), the primary event is degradation of articular cartilage — the smooth hyaline cartilage covering joint surfaces. Cartilage lacks its own blood supply and has limited intrinsic repair capacity. Under abnormal loading or after joint injury, chondrocytes (cartilage cells) become senescent and produce inflammatory mediators (IL-1, TNF-α) rather than matrix proteins. This shifts the cartilage metabolism toward degradation. Progressive thinning exposes subchondral bone, which responds with sclerosis, cyst formation, and osteophyte (bone spur) proliferation at joint margins. The classic X-ray triad — joint space narrowing, subchondral sclerosis, and osteophytes — reflects this cascade.
The key biomechanical reality: the foot is a closed kinetic chain. Arthritis in one joint alters loading across adjacent joints. Hallux rigidus (first MTP arthritis) forces the patient into lateral heel-toe transfer, overloading the lateral midfoot and ankle. Subtalar arthritis disrupts rearfoot eversion mechanics, increasing stress on the ankle. Understanding these compensatory patterns is essential to both conservative treatment design and surgical planning.
Types of Foot & Ankle Arthritis
Osteoarthritis (OA)
The most common form. In the foot, OA most commonly affects the first MTP joint (hallux rigidus), the first tarsometatarsal joint (1st TMT), and the midfoot (Lisfranc joint complex). Primary OA is related to age, genetic cartilage susceptibility, and cumulative mechanical loading. Affects approximately 15% of adults over age 60 in at least one foot joint.
Post-Traumatic Arthritis
Accounts for 80% of ankle arthritis — the ankle joint is particularly susceptible to post-traumatic arthritis after fractures, severe sprains, and osteochondral lesions. Even with anatomically perfect fracture reduction, the initial cartilage damage at the time of injury initiates an inflammatory cascade that continues for years. The average lag between ankle injury and arthritis diagnosis is 10–20 years, meaning patients often connect their current arthritis pain to long-forgotten injuries. Lisfranc injuries (midfoot fracture-dislocations) are a common and frequently missed cause of midfoot arthritis.
Rheumatoid Arthritis (RA)
A systemic autoimmune disease in which immune complex deposition and synovial pannus formation destroy cartilage and bone. The foot and ankle are involved in approximately 90% of RA patients. Characteristic RA foot findings: symmetric forefoot involvement, severe hallux valgus, lateral toe subluxation and dislocation, plantar metatarsal head prominence (causing painful calluses), and hindfoot valgus deformity from subtalar and tibiotalar involvement. RA synovitis is erosive — it invades cartilage and subchondral bone from the joint margins inward, producing the characteristic marginal erosions on X-ray. Disease-modifying antirheumatic drugs (DMARDs) — methotrexate, biologic agents — are the cornerstone of RA management and substantially reduce the rate of joint destruction when started early.
Psoriatic Arthritis (PsA)
An inflammatory arthropathy associated with psoriasis, affecting 20–30% of patients with psoriatic skin disease. In the foot, PsA characteristically produces dactylitis (diffuse sausage-like swelling of an entire toe from combined flexor tenosynovitis and small joint synovitis), enthesitis (inflammation at the Achilles tendon insertion and plantar fascia origin), and nail changes (pitting, onycholysis). Unlike RA, PsA can be asymmetric, seronegative (RF and CCP negative), and can present with arthritis before skin disease. The DIP joints (distal interphalangeal joints of the toes) are preferentially involved — unusual for RA. Imaging shows “pencil-in-cup” deformity in advanced cases.
Gouty Arthritis
Monosodium urate crystal deposition causes acute inflammatory arthritis, most commonly in the first MTP joint (podagra). Chronic, undertreated gout leads to tophaceous deposits within joints, tendons, and periarticular tissues with progressive joint destruction. X-ray in chronic gout shows “punched-out” erosions with sclerotic margins and overhanging cortical edges — distinct from both OA and RA patterns. See our gout treatment page for detailed management.
Hallux Rigidus: Grading and What It Means for Treatment
Hallux rigidus — osteoarthritis of the first metatarsophalangeal joint — is the most common site of foot OA and warrants its own discussion because staging directly determines treatment. The Coughlin and Shurnas classification (2003) is the most widely used grading system:
- Grade 0: Dorsiflexion 40–60°, no pain, no X-ray changes. Risk factor stage — may have dorsal osteophyte but no symptoms
- Grade 1: Dorsiflexion 30–40°, mild pain at extremes of motion only. X-ray shows mild dorsal osteophyte, minimal joint space narrowing. Treatment: shoe modification (rocker sole, stiff midsole), NSAIDS, cortisone injection
- Grade 2: Dorsiflexion 10–30°, moderate pain through arc of motion. X-ray shows moderate osteophytosis, up to 25% joint space loss. Treatment: above plus custom orthotics; surgical option is cheilectomy (osteophyte removal)
- Grade 3: Dorsiflexion under 10°, pain throughout arc of motion and at rest. X-ray shows severe osteophytosis, 25–75% joint space loss, possible sesamoid arthritis. Surgical options: cheilectomy with Moberg osteotomy, or arthrodesis for high-demand patients
- Grade 4: Same as Grade 3 with loss of motion in any plane, loss of cartilage on both joint surfaces. X-ray shows loss of joint space, subchondral cysts and sclerosis. Treatment is essentially surgical — arthrodesis (first MTP fusion) is the gold standard, achieving reliable pain relief with durable long-term outcomes
Key takeaway: First MTP fusion (arthrodesis) for Grade 3–4 hallux rigidus has excellent long-term outcomes. Patients maintain near-normal gait mechanics because the foot compensates through the transverse tarsal and Lisfranc joints. The “I can’t fuse the big toe joint” fear that delays treatment in many patients is not supported by outcomes data — the 10–15 year follow-up studies consistently show high patient satisfaction.
Who Gets Foot & Ankle Arthritis?
- Post-traumatic: Any history of ankle fracture, severe ankle sprain (especially with osteochondral injury), Lisfranc fracture-dislocation, or calcaneal fracture
- Age and OA: Prevalence rises sharply after 50; 85% of those over 75 have radiographic OA in at least one foot joint
- Inflammatory arthritis: Systemic RA, PsA, or gout — foot involvement should be expected and specifically examined
- High-impact activity history: Elite running, military service, prolonged standing occupations (nurses, teachers, tradespeople)
- Foot structure: Flatfoot deformity increases stress across the medial column and subtalar joint; cavus (high arch) rigidity increases ankle and lateral column loading
- Obesity: Each BMI unit increase associated with 4–5% increased OA risk; the foot bears 1.5× body weight during walking, 3× during running
Symptoms of Foot & Ankle Arthritis
- Deep, aching joint pain that is worse with weight-bearing activity and improves with rest
- Morning stiffness lasting 15–45 minutes (longer morning stiffness — over 60 minutes — suggests inflammatory rather than mechanical arthritis)
- Joint swelling and warmth (most prominent with inflammatory arthritis and post-traumatic flares)
- Crepitus — audible or palpable grinding with joint motion
- Reduced range of motion — most clinically significant at the first MTP (hallux rigidus) and ankle
- Gait changes: antalgic gait, limping, toe-out walking to avoid loading the affected joint, compensatory knee and hip pain from altered mechanics
- Inability to wear certain shoes, descend stairs normally, or run
Diagnosing Foot & Ankle Arthritis
Clinical exam: Joint-specific range of motion assessment, palpation of articular margins and joint lines, grind test for first MTP OA (axial compression with rotation reproducing pain), anterior drawer and talar tilt for ankle instability, varus/valgus stress testing. Flatfoot and cavus deformity are noted because they drive treatment selection.
Weight-bearing X-rays: Essential — imaging taken non-weight-bearing dramatically underestimates joint space narrowing. Full weight-bearing AP, lateral, and oblique views of the foot and AP/lateral mortise views of the ankle in bipedal stance are the standard. Joint space narrowing, subchondral changes, and osteophyte burden are quantified.
MRI: Used when cartilage assessment detail beyond X-ray is needed, when synovitis burden guides treatment (inflammatory arthritis), or when osteochondral lesions are suspected before committing to surgery.
Laboratory workup: For inflammatory arthritis — RF, anti-CCP (RA), uric acid (gout), HLA-B27, inflammatory markers (CRP, ESR), and skin exam for psoriatic plaques. The pattern of joint involvement, serology, and imaging together establish the arthritis subtype.
Foot & Ankle Arthritis vs. Similar Conditions
- Plantar fasciitis: Causes heel pain rather than joint pain; no X-ray joint changes; pain is typically worst with first morning steps; not associated with reduced joint range of motion
- Achilles tendinopathy: Posterior heel/ankle pain localized to the tendon, not the joint; reproducible with tendon palpation and resisted plantarflexion; no joint space changes on imaging
- Osteochondral lesion of the talus (OLT): Cartilage and bone injury on the talar dome, commonly occurring after ankle sprains. Presents with chronic ankle pain and swelling mimicking ankle arthritis, but MRI shows the focal defect rather than diffuse joint space loss. Treatment is often surgical (microfracture, osteochondral autograft) rather than the conservative-to-fusion pathway used for global ankle arthritis
- PTTD / adult-acquired flatfoot: Progressive collapse of the medial arch due to posterior tibial tendon dysfunction, causing medial ankle and arch pain, flatfoot deformity, and — in advanced stages — secondary subtalar and ankle arthritis. Often confused with isolated ankle or subtalar arthritis; the tendon pathology must be addressed as part of treatment
Treatment Options for Foot & Ankle Arthritis
Stage 1: Mechanical Offloading and Activity Modification
The foundation of conservative management is reducing mechanical load on the arthritic joint with every step. For hallux rigidus: a stiff-soled shoe with a rocker bottom sole reduces first MTP dorsiflexion by 70% with each step — this alone substantially reduces pain in Grades 1–2. Carbon fiber insole plates also effectively limit first MTP motion. For ankle and subtalar arthritis: a solid AFO (ankle-foot orthosis) or Arizona AFO brace nearly eliminates tibiotalar and subtalar motion, providing dramatic symptomatic relief while avoiding surgery. Activity modification — substituting swimming, cycling, or water aerobics for high-impact activities — reduces cumulative daily joint loading.
Stage 2: Anti-inflammatory Treatment
Oral NSAIDs (naproxen, meloxicam, diclofenac) reduce synovial inflammation and pain. Topical diclofenac gel delivers equivalent anti-inflammatory efficacy to the joint with minimal systemic absorption — preferred for elderly patients or those with GI, cardiac, or renal risk factors. For inflammatory arthritis (RA, PsA), disease-modifying antirheumatic drugs prescribed by rheumatology are the priority — NSAIDs treat symptoms but not the underlying immune mechanism.
Stage 3: Custom Orthotics
Custom-molded foot orthotics redistribute plantar pressure away from arthritic joints. For midfoot and subtalar arthritis, a rigid custom orthotic with a deepened heel cup and appropriate arch support redistributes load to non-arthritic regions. For hallux rigidus, a rigid Morton’s extension (carbon plate extending under the first MTP) prevents dorsiflexion and eliminates the most painful arc of motion. Orthotics are most effective when combined with appropriate footwear — a stiff midsole shoe amplifies orthotic benefit; a soft-soled shoe negates it.
Stage 4: Joint Injections
Corticosteroid injections (triamcinolone, betamethasone) into arthritic joints reduce synovial inflammation and provide 2–6 months of pain relief per injection. We perform these under ultrasound or fluoroscopic guidance for precise intra-articular delivery. Typically limited to 3–4 injections per joint per year — more frequent injection may accelerate cartilage degradation.
Hyaluronic acid (viscosupplementation): Injection of synthetic joint fluid into the arthritic joint to reduce friction and pain. Evidence is stronger for knee OA; for foot joints the data is less robust, but some patients — particularly those who cannot tolerate corticosteroids — benefit. Not appropriate for active inflammatory flares.
Platelet-rich plasma (PRP): An emerging option using concentrated autologous growth factors to reduce inflammation and potentially support cartilage repair. Evidence quality is improving but not yet definitive; we offer PRP as an option for patients seeking an alternative to corticosteroids with longer potential duration of effect.
Stage 5: Surgical Options
Cheilectomy (for Grade 1–3 hallux rigidus): Removal of dorsal osteophytes and 25–30% of the dorsal metatarsal head to restore dorsiflexion range and eliminate bony impingement. Excellent outcomes in appropriately graded cases (adequate remaining joint space). Failure rate increases significantly if performed on Grade 3–4 joints with diffuse cartilage loss.
Moberg osteotomy: A dorsal closing wedge osteotomy of the proximal phalanx that mechanically increases effective dorsiflexion by shifting the arc of motion. Often combined with cheilectomy for Grade 2–3 hallux rigidus in active patients.
Arthrodesis (fusion): Permanent stabilization of the joint by fusing opposing bone surfaces. For the first MTP joint (Grade 3–4 hallux rigidus), fusion at the appropriate angle (10–15° dorsiflexion, 10–15° valgus) eliminates pain reliably while preserving near-normal gait. For ankle arthritis, tibiotalar fusion eliminates pain with modest functional limitation — patients typically walk, bike, and swim normally. Subtalar fusion addresses rearfoot arthritis with excellent outcomes. The Lisfranc joint complex can be fused selectively. Modern internal fixation (retrograde intramedullary nail for ankle; compression screws or plates for smaller joints) achieves high fusion rates and early protected weight-bearing.
Total ankle replacement (TAR): Third-generation total ankle arthroplasty systems now achieve 80–90% survivorship at 10 years in appropriately selected patients. TAR preserves ankle motion — the key functional advantage over fusion — and reduces the stress transfer to adjacent joints that follows fusion. Ideal for older, lower-demand patients with good bone stock, no significant deformity, and intact ligamentous stability. Younger, higher-demand patients remain better candidates for fusion.
Most Common Mistakes
- Imaging without weight-bearing: Non-weight-bearing X-rays underestimate joint space narrowing significantly — arthritic joints that appear acceptable non-weight-bearing can show severe cartilage loss when imaged under load. Always insist on weight-bearing studies for foot and ankle arthritis evaluation.
- Using a “one-size-fits-all” orthotic for all foot arthritis: OA at the first MTP requires rigid plate extension; midfoot OA requires a different arch contour; subtalar arthritis requires rearfoot control. Generic insoles address none of these specifically. The orthotic must be designed for the specific arthritic joint, not “foot pain” in general.
Red Flags — When to See a Podiatrist Immediately
- Sudden increase in redness, warmth, and swelling in an arthritic joint — may indicate superimposed septic arthritis, acute gout flare, or fracture; requires aspiration to distinguish
- Progressive foot or ankle deformity — worsening flatfoot collapse, toe dislocation, or ankle varus/valgus drift suggests ligament failure or tendon rupture requiring urgent evaluation
- Loss of skin integrity over a tophus or bony prominence — open ulcers over arthritic prominences in diabetic or neuropathic patients risk deep infection and osteomyelitis
- New foot pain after ankle fracture, even years later — post-traumatic arthritis developing after a fracture is common but often attributed to other causes; any significant ankle pain after prior fracture warrants weight-bearing X-ray comparison
- Constitutional symptoms (fever, weight loss, night sweats) with joint pain — raises concern for inflammatory arthritis, malignancy, or infection; requires systemic workup beyond the foot
In-Office Treatment at Balance Foot & Ankle
Dr. Tom Biernacki and the Balance Foot & Ankle team manage the full spectrum of foot and ankle arthritis — from conservative management with custom orthotics and ultrasound-guided injections to surgical arthrodesis and total ankle replacement. We have on-site weight-bearing digital X-ray, musculoskeletal ultrasound, and custom orthotics laboratory at both our Howell and Bloomfield Hills locations. Most major Michigan insurance plans accepted. Same-week appointments available.
Howell: 4330 E Grand River Ave, Howell MI 48843
Bloomfield Hills: 43494 Woodward Ave #208, Bloomfield Hills MI 48302
Phone: (810) 206-1402 | Book online →
Sources
- Coughlin MJ, Shurnas PS. Hallux rigidus: grading and long-term results of operative treatment. J Bone Joint Surg Am. 2003;85(11):2072–2088.
- Saltzman CL, et al. Prospective controlled trial of STAR total ankle replacement versus ankle fusion: initial results. Foot Ankle Int. 2009;30(7):579–596.
- Valderrabano V, et al. Etiology of ankle osteoarthritis. Clin Orthop Relat Res. 2009;467(7):1800–1806.
- Coester LM, et al. Long-term results following ankle arthrodesis for post-traumatic arthritis. J Bone Joint Surg Am. 2001;83(2):219–228.
- Bellemans J, et al. Rheumatoid arthritis of the foot and ankle. Clin Rheumatol. 2007;26(7):1097–1102.
- Brodsky JW. Arthritis of the foot and ankle. In: Coughlin MJ, Mann RA, Saltzman CL, eds. Surgery of the Foot and Ankle. 8th ed. Mosby Elsevier; 2007.
Chronic Foot or Ankle Pain? Get a Weight-Bearing Evaluation Today.
On-site X-ray, ultrasound & custom orthotics — Howell & Bloomfield Hills, MI
4.9★ | 1,123 Reviews | 3,000+ Surgeries
Or call: (810) 206-1402
In-Office Treatment at Balance Foot & Ankle
If home treatment isn’t providing relief for your ankle or foot arthritis, our podiatry team at Balance Foot & Ankle can help with same-day evaluations and advanced in-office care.
OrthoInfo – AAOS: Arthritis of the Foot and Ankle
Ready to Get Relief?
Same-day appointments available in Howell & Bloomfield Hills, MI
4.9★ | 1,123 Reviews | 3,000+ Surgeries
Or call: (810) 206-1402
Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.
Frequently Asked Questions
Can a podiatrist treat arthritis in the foot?
How much does a podiatrist visit cost without insurance?
- Plantar Fasciitis: Diagnosis and Conservative Management (PubMed)
- Plantar Fasciitis (APMA)
- Diagnosis and Treatment of Plantar Fasciitis (PubMed / AAFP)
- Heel Pain (APMA)
Related Treatments at Balance Foot & Ankle
Our board-certified podiatrists offer advanced treatments at our Bloomfield Hills and Howell locations.
Recommended Products from Dr. Tom
